University COVID-19 Information Plasma Donors Needed
SOM COVID-19 INFO: Students | Research | BMS Students | Residents/Fellows | Dean's Town Hall | SOM Employees
M20-178 A Randomized, Open-Label, Phase 3 Study Evaluating Efficacy and Safety of Navitoclax in Combination With Ruxolitinib Versus Best Available Therapy in Subjects With Relapsed Refractory Myelofibrosis (TRANSFORM-2) More Information
